Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Norepinephrine Transporter Blockade, Autonomic Failure (NETAF) is a clinical trial[1].
Key Facts
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF) is in the country of United States[2].
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)'s instance of is recorded as clinical trial[3].
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)'s start time is recorded as +2016-08-29T00:00:00Z[4].
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)'s end time is recorded as +2020-07-31T00:00:00Z[5].
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)'s sponsor is recorded as Vanderbilt University Medical Center[6].
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)'s number of participants is recorded as {'unit': '1', 'amount': '+40'}[7].
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)'s title is recorded as Phase 2 Norepinephrine Transporter Blockade, Autonomic Failure IND117394 12/28/12[8].
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)'s short name is recorded as NETAF[9].
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+40'}[10].
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)'s ClinicalTrials.gov ID is recorded as NCT02784535[11].
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)'s maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+80'}[12].
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)'s research intervention is recorded as norepinephrine[13].
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)'s research intervention is recorded as atomoxetine hydrochloride[14].
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)'s clinical trial phase is recorded as phase II clinical trial[15].
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)'s principal investigator is recorded as Cyndya A. Shibao[16].
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)'s study type is recorded as interventional study[17].